All Faculty Members
Marissa B Wilck, MBChB, DTM&H, MS
Assistant Professor of Clinical Medicine
Attending Physician, Hospital of the University of Pennsylvania
Chief Medical Officer, Penn Home Infusion Therapy (PHIT), University of Pennsylvania Health System
Faculty of Health Sciences, University of Cape Town, South Africa , 1996.
(Diploma in Tropical Medicine and Hygiene)
London School of Tropical Medicine and Hygiene, London, England, 1999.
(Masters in Health Sciences and Technology)
Harvard, MIT Division of Health Sciences and Technology, Beth Israel Deaconess Medical Center, Boston, MA, 2010.
Intern in Medicine, Groote Schuur Hospital, Cape Town, South Africa
Fellow in Clinical Microbiology, Yale New Haven Hospital, New Haven, CT
Intern in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC
Resident in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC
Chief Resident in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC
Clinical Fellow in Medicine, Harvard Medical School Boston, MA
Clinical and Research Fellow in Infectious Diseases, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA.
Board Certified in Internal Medicine ABIM, 2004.
Board Certified in Infectious Diseases ABIM, 2006.
Schneeweiss, Sebastian; Carver, Peggy; Datta, Kausik; Galar, Alicia; Johnson, Melissa; Johnson, Matthew; Marty, Francisco; Nagel, Jerod; Najdzinowicz, Maryann ; Saul, Melissa; Shoham, Shmuel; Silveira, Fernanda ; Varughese, Christine ; Wilck, Marissa; Weatherby, Lisa; Auton, Tim; Walker, Alexander: Short-term Risk of Liver and Renal Injury in Hospitalized Patients Using Micafungin – A Multicenter Cohort Study.
Journal of Antimicrobial Chemotherapy 71(10): 2938-44, Oct 2016
Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EA.: Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis 18(5): 777-781, Oct 2016
Forrestel AK, Modi BG, Longworth S, Wilck MB, Micheletti RG: Primary Cutaneous Cryptococcus in a Patient with Multiple Sclerosis Treated with Fingolimod
JAMA Neurology 73(3): 355-356, Mar 2016.
Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Haynes BF, Montefiore DC, Tomaras GD, McElrath JM, Hura J, Graham BS, Jin X, HVTN 083 Study Group, NIAID HIV Vaccine Trials Network: Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). Journal of Infectious Disease
Page: pii: jiv496, October 2015 Notes: Epub ahead of print.
Wilck MB and Blumberg EA: Donor Derived Infections After Organ Transplantation. Textbook of Organ Transplantation. Allan D. Kirk, Stuart J. Knechtle, Christian P. Larsen, Joren C. Madsen, Thomas C. Pearson, Steven A. Webber (eds.). John Wiley & Sons Ltd
Page: 1088-1104, July 2014 Notes: Chapter 92.
Sparkes, Gonzales, Blumberg EA, Wilck MB: A Comparison of Cryptococcal Meningitis in Solid Organ Transplant Recipients Versus Human Immunodeficiency Virus-Infected Individuals T-825c
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, CO September 2013 Notes: Poster presentation.
Wine-Lee L, Keller SC, Wilck MB, Gluckman SJ, Van Voorhees AS: From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. Journal of the American Academy of Dermatology 69(6): 1003-1013, Sep 2013.
Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR: Safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. The Journal of Infectious Diseases 207(12): 1888, June 2013.
Stevens DR, Trofe-Clark J, Blumberg E, Wilck M, Weikert B, Goral S, Bleicher M, Sawinski D, Abt P, Naji A, Levine M, Porrett P, MD, Bloom RD: Increased Risk of Breakthrough Infection Among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower Dose Valganciclovir Prophylaxis. American Transplant Congress (ATC), Washington State Convention Center
May 2013 Notes: Poster presentation.
Wilck MB, Zuckerman RA; AST Infectious Diseases Community of Practice: Herpes simplex virus in solid organ transplantation. American Journal of Transplantation
Supplement 4: 121-127, March 2013.
back to top
Last updated: 10/17/2016
The Trustees of the University of Pennsylvania